Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
By P. Jiang, Carol W. M. Chan, K. C. Chan, S. Cheng, J. Wong, Vincent W.S. Wong, G. Wong, S. Chan, T. Mok, H. Chan and 3 more. Proceedings of the National Academy of Sciences of the United States of America, 2015
649 citations recorded by the source corpus.
Subfields: Cancer Research, Oncology
View Paper: https://www.semanticscholar.org/paper/bf8a4cb0b8e4926ad200c215b8247c1f686fa6f7
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
Citations in the corpus
- Novel insights into Notum and glypicans regulation in colorectal cancer (2015, background): “In this view, the analysis of the genomic instability resulting in copy number aberrations through massive parallel sequencing, as already demonstrated for prostate cancer [11] or the detection of tumorderived circulating cell-free DNA in plasma samples [12] could represent new possibilities for the”
- Fragment Length of Circulating Tumor DNA (2016, methodology): “However, this latter study also identified fragment lengths larger than healthy controls associated with low ctDNA concentrations in patients with hepatocellular carcinoma which is difficult to reconcile [17].”